Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for TuHURA Biosciences Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
B
BlackRock, Inc.
|
690.1K | 1.08% | −1.8M (−71.8%) | 2024 | 0.0% | |
|
Shares held by quarter
Peak holding2.5M (Q1'26)
Change over 8 quarters+690.1K
Share of the company1.080%
|
||||||
|
VC
Vanguard Capital Management LLC
|
2.3M | 3.56% | +193.7K (+9.3%) | 2024 | 0.0% | |
|
Shares held by quarter
Peak holding2.3M (Q2'26)
Change over 8 quarters+2.3M
Share of the company3.560%
|
||||||
28 more super investors behind a free account
See every manager holding TuHURA Biosciences Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$4.07M | 1.7M | 2.73% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$1.72M | 963.2K | 1.51% | 0.00% | March 31, 2026 |
23 more funds behind a free account
See every fund holding TuHURA Biosciences Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
JA
James A. Bianco, M.D.
5%+ holder
13D · 4.6%
|
3.1M | 4.84% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
Loading...